Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03342703 · ClinicalTrials.gov registry record
Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI
A clinical trial of Liver Cirrhosis and Liver Steatoses, sponsored by Stanford University.
- Completed
- Registry status
- 35
- Enrollment target
- 2
- Study locations
NCT03342703: Completed study of Liver Cirrhosis and Liver Steatoses, sponsored by Stanford University.
NCT03342703 is a study of Liver Cirrhosis and Liver Steatoses that has completed, run by Stanford University. The registered enrollment target is 35 participants, below the 1,003-participant average among 15 other Liver Cirrhosis trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03342703, a study of Liver Cirrhosis and Liver Steatoses, has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators will assess the ability of ultrasound (US) to measure liver stiffness (cirrhosis) and liver fat content (steatosis).
Primary Outcome
Discriminatory value (the ability of the test to diagnose disease from healthy) will be calculated using nonparametric receiver operating characteristic (ROC) curve analysis. Sensitivity (i.e. true positive rate: the ability of a test to correctly identify patients with the disease being investigated) is plotted on the y axis and 1-specificity (i.e. false positive rate: the test incorrectly identifies patients who do not have the disease being investigated as having the disease) will be plotted
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Ultrasound
Study Locations (2)
California
- Stanford University Hospital - Stanford
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2018-08-01 |
| Est. Completion | 2020-12-31 |
What the finished NCT03342703 record still lists
NCT03342703 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target, below the 1,003-participant average among 15 other Liver Cirrhosis trials with a reported enrollment target (97% lower).
The record links to 2 conditions, with Liver Cirrhosis appearing as the primary indexed condition, and to 1 intervention - of which Ultrasound is the first listed.
NCT03342703 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03342703 about?
NCT03342703 is a clinical study titled "Correlation of Ultrasound Based Measurements of Liver Stiffness and Steatosis With MRI". The investigators will assess the ability of ultrasound (US) to measure liver stiffness (cirrhosis) and liver fat content (steatosis).
What is the current status of trial NCT03342703?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2018-08-01. Estimated completion is 2020-12-31.
What conditions does trial NCT03342703 study?
This clinical trial studies the following conditions: Liver Cirrhosis, Liver Steatoses.
What interventions are being tested in trial NCT03342703?
The interventions under investigation include: Ultrasound (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03342703?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03342703 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Cirrhosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03342703's enrollment target sits among peer trials
35 14th of 15 higher than 2 of 15 other Liver Cirrhosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Liver Cirrhosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
National Liver Cancer Screening Trial
RECRUITING · Phase 4
-
Multi-analyte Blood Test Clinical Trial
RECRUITING
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
RECRUITING · NA
-
Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis
RECRUITING
-
A Study to Test Whether BI 3802876 is Tolerated in People With Compensated Liver Cirrhosis Due to Metabolic Dysfunction- Associated Steatohepatitis (MASH)
RECRUITING · Phase 2
-
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI